The former vice president of a pharmaceutical company was sentenced to 33 months for pushing unnecessary opioid prescriptions

  • 📰 CNN
  • ⏱ Reading Time:
  • 24 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 95%

ประเทศไทย ข่าว ข่าว

ประเทศไทย ข่าวล่าสุด,ประเทศไทย หัวข้อข่าว

The former vice president of a pharmaceutical company was sentenced to almost three years for pushing doctors to prescribe unnecessary opioids on patients, the US Attorney's Office says.

Michael Gurry, 56, of Scottsdale, Arizona, was sentenced to 33 months plus three years of supervised release for his role in a conspiracy to bribe medical practitioners to prescribe Subsys, a powerful fentanyl-based medication, the release said.Gurry is one of five employees of Insys Therapeutics convicted of racketeering conspiracy in the scheme.

He told employees of that center to misrepresent themselves as employees of the prescribing office in order to obtain prior authorization of payment from insurance companies and pharmacy benefit managers.Read MoreGurry authorized employees to use a script, referred to in the release as"the spiel" in order to trick insurers into thinking the patient had been prescribed Subsys for the treatment of breakthrough cancer pain, the release said.

 

ขอบคุณสำหรับความคิดเห็นของคุณ ความคิดเห็นของคุณจะถูกเผยแพร่หลังจากได้รับการตรวจสอบแล้ว

'Michael Gurry, 56, of Scottsdale, Arizona, was sentenced to 33 months plus three years of supervised release' The Supervised Release Program reduces the number of people held in jail simply because they cannot afford bail. Translation: Money gets you out. Vote BernieSanders

Omg 😮

Watch video taken from plane shot down by iran

Let us investigate ALL marketing by drug companies to doctors!

Just 3? How many years other drug traffickers got? I should be surprised at this anymore. I think i should accept the peeking justice.

เราได้สรุปข่าวนี้มาให้อ่านอย่างรวดเร็ว หากสนใจข่าว สามารถอ่านฉบับเต็มได้ที่นี่ อ่านเพิ่มเติม:

 /  🏆 4. in TH

ประเทศไทย ข่าวล่าสุด, ประเทศไทย หัวข้อข่าว